Kagan G, Rose R
Curr Med Res Opin. 1977;5(2):200-3. doi: 10.1185/03007997709110165.
A single-blind, between-patient comparative study was carried out in general practice to assess the effectiveness of antacid plus antispasmodic combination tablets (240 mg dried aluminium hydroxide B.P., 144 mg magnesium hydroxide B.P.C., and 5 mg dicyclomine hydrochloride B.P.) and aluminium hydroxide B.P. tablets (500 mg) in the management of chronic dyspepsia. Twenty patients received the combination tablets and 17 the single antacid tablets. They were instructed to chew 2 tablets 3 or 4-times daily and an additional 2 tablets at night if necessary. Patients were assessed initially, and then at 2 and 4 weeks. Both preparations were effective in controlling dyspeptic symptoms. Heartburn and nausea showed an early, significantly greater (p less than 0.05) response to the combined tablet, as did night pain after 4 weeks. Tablet intake of both preparations averaged out at just under 7 tablets per day.
在普通医疗实践中开展了一项单盲、患者间对照研究,以评估抗酸剂加解痉组合片剂(240毫克英国药典干燥氢氧化铝、144毫克英国药典委员会氢氧化镁和5毫克英国药典盐酸双环胺)和英国药典氢氧化铝片剂(500毫克)治疗慢性消化不良的效果。20名患者服用组合片剂,17名患者服用单一抗酸剂片剂。他们被指示每天咀嚼2片,每日3或4次,必要时晚上额外再嚼2片。对患者进行了初始评估,然后在2周和4周时再次评估。两种制剂在控制消化不良症状方面均有效。烧心和恶心对组合片剂的早期反应显著更大(p<0.05),4周后的夜间疼痛也是如此。两种制剂的片剂摄入量平均每天略低于7片。